Cargando…
KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model
BACKGROUND: Endothelial progenitor cells (EPCs) are regarded as promising targeted vectors for delivering therapeutic genes or agents in cancer therapy. The purpose of this study was to investigate the role of intravenously administered KAI1/CD82 genetically transduced EPCs in the tumorigenesis and...
Autores principales: | Wang, Gengming, Zhang, Lei, Zhou, Yan, Sun, Qian, Xu, Hongbo, Cai, Feng, Xiang, Ping, Chen, Zhendong, Jiang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975073/ https://www.ncbi.nlm.nih.gov/pubmed/29755107 http://dx.doi.org/10.12659/MSM.907219 |
Ejemplares similares
-
Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
por: WANG, GENGMING, et al.
Publicado: (2015) -
Role of Metastasis Suppressor KAI1/CD82 in Different Cancers
por: Yan, Wei, et al.
Publicado: (2021) -
Mechanical Control of Cell Migration by the Metastasis Suppressor Tetraspanin CD82/KAI1
por: Ordas, Laura, et al.
Publicado: (2021) -
Role of the metastasis suppressor tetraspanin CD82/KAI 1 in regulation of signalling in breast cancer cells
por: Odintsova, E, et al.
Publicado: (2006) -
Survey of Two New (Kai 1 and Kai 2) and Other Blood Groups in Dogs of North America
por: Euler, C.C., et al.
Publicado: (2016)